Description
The finding that insulin signaling can alter tau isoforms raises the question of whether metabolic dysregulation contributes to the tau isoform imbalances seen in Alzheimer’s disease and other tauopathies. This connection between metabolism and tau pathology remains unexplored but could reveal new therapeutic targets.
Gap type: open_question Source paper: 4R-tau isoform induction via TDP-43 in neurons in response to insulin: converging signaling pathways with implications for neurodegenerative disease. (None, None, PMID:41444683)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:50.915062+00:00”, “resolution_summary”: “Resolved by hypothesis h-183fff58: TDP-43 Pathology Disrupts the HGS-PYGB Autophagy Receptor Cascade in Motor Neurons. Supporting evidence includes debate sess_SDA-2026-04-07-gap-pubmed-20260406-062202-c8c5a9a1_task_9aae8fc5.”, “match_counts”: {“hypothesis_matches”: 4, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-183fff58”, “title”: “TDP-43 Pathology Disrupts the HGS-PYGB Autophagy Receptor Cascade in Motor Neurons”, “score”: 0.25, “reason”: “6 token overlaps; entity overlap: tdp-43”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c”, “target_gene”: “TARDBP (TDP-43), HGS, PYGB”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.7030000000000001, “confidence_score”: 0.72, “status”: “proposed”, “pubmed_evidence_ids”: [“19023281”, “28760759”, “29417807”, “29507358”]}, {“id”: “h-alsmnd-54f981ca6a25”, “title”: “TIA1 Low-Complexity Domain Oxidation Drives Aberrant Stress Granule Assembly and TDP-43 Mislocalization in ALS Motor Neurons”, “score”: 0.243, “reason”: “9 token overlaps; entity overlap: tdp-43”, “analysis_id”: null, “target_gene”: “TIA1,TDP-43,TARDBP,G3BP1,MAPK1,Oxidative stress response”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.81, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“23092511”, “34378050”, “34750982”, “36499097”]}, {“id”: “h-alsmnd-9d62ae58bdc1”, “title”: “RBM45 Liquid-Liquid Phase Separation Dominance Hijacks RNA Processing Condensates Toward Pathological Aggregation in ALS”, “score”: 0.234, “reason”: “8 token overlaps; entity overlap: tdp-43”, “analysis_id”: null, “target_gene”: “RBM45,GSK3B,TDP-43,TARDBP,hnRNP A1,HNRNPA1,phase separation,Liquid droplet”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.868053, “confidence_score”: 0.75, “status”: “open”, “pubmed_evidence_ids”: [“22993125”, “25939382”, “29140459”, “32586379”, “34118419”]}, {“id”: “h-530326b97069”, “title”: “SASP-Secreted MMP-9 from Senescent Microglia Generates Pathological TDP-43 C-Terminal Fragments That Propagate ALS Pathology”, “score”: 0.231, “reason”: “8 token overlaps; entity overlap: tdp-43”, “analysis_id”: “SDA-2026-04-26-gap-20260425215446”, “target_gene”: “MMP9 → TARDBP (C-terminal fragments) → cytoplasmic aggregation seeding”, “target_pathway”: null, “disease”: “ALS”, “composite_score”: 0.713424, “confidence_score”: 0.3, “status”: “proposed”, “pubmed_evidence_ids”: [“21209826”, “30458231”, “33300249”, “39067491”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062202-c8c5a9a1_task_9aae8fc5”, “title”: “The abstract identifies APOE4 association with increased TDP-43 pathology but the mechanistic link is unexplained. This connection could reveal novel therapeutic targets since APOE4 is the strongest genetic risk factor for AD.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Pathology in Alzheimer’s Disease. (2021, Mol Neurodegener, PMID:34930382)”, “score”: 0.599, “reason”: “12 token overlaps; entity overlap: pmid, tdp-43”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062202-c8c5a9a1”, “quality_score”: 0.61, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062202-5c32c50a_task_9aae8fc5”, “title”: “AD patients with TDP-43 pathology show worse cognitive impairment, but how TDP-43 mechanistically contributes to this severity is unknown. Understanding this could identify TDP-43 as a therapeutic target for cognitive preservation in AD.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Pathology in Alzheimer’s Disease. (2021, Mol Neurodegener, PMID:34930382)”, “score”: 0.57, “reason”: “10 token overlaps; entity overlap: pmid, tdp-43”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062202-5c32c50a”, “quality_score”: 0.734, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062202-094b44bf_task_9aae8fc5”, “title”: “TDP-43 inclusions occur in AD, ALS, and FTLD but the pathogenic mechanisms leading to TDP-43 pathology may differ between diseases. Understanding disease-specific drivers could reveal why TDP-43 shows limbic distribution in AD versus other patterns in ALS/FTLD.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Pathology in Alzheimer’s Disease. (2021, Mol Neurodegener, PMID:34930382)”, “score”: 0.519, “reason”: “9 token overlaps; entity overlap: pmid, tdp-43”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062202-094b44bf”, “quality_score”: 0.697, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-08-gap-pubmed-20260406-062141-739c7f1c_task_9aae8fc5”, “title”: “While the study demonstrates TDP-43 triggers mPTP-mediated mtDNA release, the molecular mechanism by which TDP-43 pathology leads to mPTP opening is not explained. Identifying this upstream trigger could reveal more proximal therapeutic targets than downstream cGAS/STING inhibition.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. (2020, Cell, PMID:33031745)”, “score”: 0.515, “reason”: “10 token overlaps; entity overlap: pmid, tdp-43”, “analysis_id”: “SDA-2026-04-08-gap-pubmed-20260406-062141-739c7f1c”, “quality_score”: 0.772, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046_task_9aae8fc5”, “title”: “While the study establishes TDP-43 triggers mtDNA release via mPTP to activate cGAS/STING, it’s unclear why this pathway preferentially affects motor neurons in ALS when TDP-43 pathology occurs in multiple cell types. Understanding this selectivity is crucial for targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. (2020, Cell, PMID:33031745)”, “score”: 0.484, “reason”: “9 token overlaps; entity overlap: pmid, tdp-43”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062141-611cf046”, “quality_score”: 0.734, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}